Dr. Nathaniel Treister presents on oral medicine for head and neck oncology

More than 70 students, residents, and faculty members turned out on February 20, 2019, for a lecture on oral medicine for head and neck oncology by Nathaniel Treister, DMD, DMSc that was hosted by the Henry M. Goldman School of Dental Medicine.

“We are very grateful to Dr. Treister for sharing his expertise in this vital area with the GSDM community,” said Dr. Maria Kukuruzinska, associate dean for research at GSDM. “Understanding the issues faced by this vulnerable population is vital to ensuring that cancer patients and survivors receive the best possible oral healthcare.”

According to Treister, common cancer therapies such as chemotherapy, radiation, and surgery can result in oral complications including oral mucositis, infections, chronic pain, and salivary hypofunction. It is vital for dentists and clinicians to understand the causes and impact of these complications in order to provide excellent care for those who have undergone or are currently undergoing cancer treatments, he said.

Treister is the chief of oral medicine and dentistry at Brigham & Women’s Hospital and Dana-Farber Cancer Institute, and an assistant professor of oral medicine, infection, and immunity at Harvard School of Dental Medicine. He also serves as an associate surgeon at Dana-Farber/Brigham and Women’s Cancer Center and is a consulting staff member at Boston Children’s Hospital. Oral complications of cancer therapies are one of Dr. Treister’s primary clinical interests. In his research, he seeks to better understand the pathology of these oral complications and how best to manage and improve outcomes.